nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—PTGS2—skin cancer	0.269	1	CbGaD
Acetaminophen—CYP1A2—Imiquimod—skin cancer	0.0522	0.101	CbGbCtD
Acetaminophen—CYP1A1—Dacarbazine—skin cancer	0.0491	0.0947	CbGbCtD
Acetaminophen—CYP2C8—Vismodegib—skin cancer	0.0468	0.0902	CbGbCtD
Acetaminophen—CYP2E1—Dacarbazine—skin cancer	0.0379	0.0732	CbGbCtD
Acetaminophen—CYP2A6—Fluorouracil—skin cancer	0.0337	0.065	CbGbCtD
Acetaminophen—CYP2C9—Vismodegib—skin cancer	0.0326	0.0629	CbGbCtD
Acetaminophen—ABCB1—Vismodegib—skin cancer	0.0317	0.0611	CbGbCtD
Acetaminophen—CYP1A2—Vemurafenib—skin cancer	0.0286	0.0552	CbGbCtD
Acetaminophen—CYP3A4—Temozolomide—skin cancer	0.0274	0.0528	CbGbCtD
Acetaminophen—CYP3A4—Imiquimod—skin cancer	0.0274	0.0528	CbGbCtD
Acetaminophen—CYP2D6—Vemurafenib—skin cancer	0.0236	0.0455	CbGbCtD
Acetaminophen—CYP1A2—Dacarbazine—skin cancer	0.0219	0.0423	CbGbCtD
Acetaminophen—CYP3A4—Vismodegib—skin cancer	0.019	0.0366	CbGbCtD
Acetaminophen—ABCB1—Dactinomycin—skin cancer	0.0166	0.0321	CbGbCtD
Acetaminophen—CYP2C8—Fluorouracil—skin cancer	0.0166	0.0321	CbGbCtD
Acetaminophen—CYP3A4—Vemurafenib—skin cancer	0.015	0.0289	CbGbCtD
Acetaminophen—CYP1A2—Fluorouracil—skin cancer	0.0129	0.0248	CbGbCtD
Acetaminophen—CYP2C9—Fluorouracil—skin cancer	0.0116	0.0224	CbGbCtD
Acetaminophen—ABCB1—Docetaxel—skin cancer	0.00859	0.0166	CbGbCtD
Acetaminophen—CYP3A4—Docetaxel—skin cancer	0.00515	0.00993	CbGbCtD
Acetaminophen—TRPV1—nerve—skin cancer	0.00422	0.0847	CbGeAlD
Acetaminophen—SULT1E1—nipple—skin cancer	0.00316	0.0634	CbGeAlD
Acetaminophen—SULT1A1—neck—skin cancer	0.00269	0.054	CbGeAlD
Acetaminophen—SULT1E1—mammalian vulva—skin cancer	0.00185	0.0371	CbGeAlD
Acetaminophen—SULT2A1—female reproductive system—skin cancer	0.00171	0.0344	CbGeAlD
Acetaminophen—SULT1E1—lymphoid tissue—skin cancer	0.00164	0.0329	CbGeAlD
Acetaminophen—PTGS2—leg—skin cancer	0.00162	0.0326	CbGeAlD
Acetaminophen—TRPV1—epithelium—skin cancer	0.00161	0.0324	CbGeAlD
Acetaminophen—SULT1E1—female reproductive system—skin cancer	0.00158	0.0317	CbGeAlD
Acetaminophen—PTGS2—hindlimb—skin cancer	0.00145	0.0291	CbGeAlD
Acetaminophen—SULT2A1—head—skin cancer	0.00143	0.0287	CbGeAlD
Acetaminophen—SULT1A1—female reproductive system—skin cancer	0.00136	0.0273	CbGeAlD
Acetaminophen—UGT2B15—female reproductive system—skin cancer	0.00131	0.0264	CbGeAlD
Acetaminophen—PTGS2—appendage—skin cancer	0.00124	0.0249	CbGeAlD
Acetaminophen—CYP1A1—skin epidermis—skin cancer	0.00123	0.0247	CbGeAlD
Acetaminophen—TRPV1—female reproductive system—skin cancer	0.0012	0.024	CbGeAlD
Acetaminophen—SULT1A1—head—skin cancer	0.00114	0.0228	CbGeAlD
Acetaminophen—PTGS2—skin epidermis—skin cancer	0.00103	0.0207	CbGeAlD
Acetaminophen—SULT2A1—lymph node—skin cancer	0.001	0.0201	CbGeAlD
Acetaminophen—TRPV1—head—skin cancer	0.001	0.0201	CbGeAlD
Acetaminophen—SULT1E1—lymph node—skin cancer	0.000924	0.0186	CbGeAlD
Acetaminophen—CNR1—lymph node—skin cancer	0.000865	0.0174	CbGeAlD
Acetaminophen—SULT1A1—lymph node—skin cancer	0.000796	0.016	CbGeAlD
Acetaminophen—PTGS1—endothelium—skin cancer	0.000784	0.0158	CbGeAlD
Acetaminophen—PTGS2—endothelium—skin cancer	0.00075	0.0151	CbGeAlD
Acetaminophen—CNR1—Small Ligand GPCRs—PTGER4—skin cancer	0.000744	0.0696	CbGpPWpGaD
Acetaminophen—PTGS1—blood vessel—skin cancer	0.000723	0.0145	CbGeAlD
Acetaminophen—PTGS2—blood vessel—skin cancer	0.000691	0.0139	CbGeAlD
Acetaminophen—CYP1A2—nipple—skin cancer	0.000603	0.0121	CbGeAlD
Acetaminophen—CYP1A1—nipple—skin cancer	0.000595	0.012	CbGeAlD
Acetaminophen—PTGS1—nipple—skin cancer	0.000523	0.0105	CbGeAlD
Acetaminophen—SULT2A1—Corticotropin-releasing hormone—KRT14—skin cancer	0.000503	0.0471	CbGpPWpGaD
Acetaminophen—ABCB1—blood vessel—skin cancer	0.000428	0.00859	CbGeAlD
Acetaminophen—SULT2A1—PPARA activates gene expression—PLIN2—skin cancer	0.00041	0.0384	CbGpPWpGaD
Acetaminophen—SULT2A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.000401	0.0375	CbGpPWpGaD
Acetaminophen—CYP1A1—epithelium—skin cancer	0.000401	0.00805	CbGeAlD
Acetaminophen—CYP1A1—skin of body—skin cancer	0.000381	0.00765	CbGeAlD
Acetaminophen—SULT2A1—E2F transcription factor network—XRCC1—skin cancer	0.000374	0.035	CbGpPWpGaD
Acetaminophen—PTGS1—connective tissue—skin cancer	0.000371	0.00745	CbGeAlD
Acetaminophen—PTGS2—connective tissue—skin cancer	0.000355	0.00712	CbGeAlD
Acetaminophen—PTGS1—epithelium—skin cancer	0.000352	0.00707	CbGeAlD
Acetaminophen—CYP1A1—mammalian vulva—skin cancer	0.000348	0.00698	CbGeAlD
Acetaminophen—PTGS2—epithelium—skin cancer	0.000337	0.00676	CbGeAlD
Acetaminophen—PTGS1—skin of body—skin cancer	0.000335	0.00672	CbGeAlD
Acetaminophen—CYP2C8—female reproductive system—skin cancer	0.000323	0.00648	CbGeAlD
Acetaminophen—PTGS2—skin of body—skin cancer	0.00032	0.00643	CbGeAlD
Acetaminophen—Erythema multiforme—Dactinomycin—skin cancer	0.000307	0.00202	CcSEcCtD
Acetaminophen—Dyspepsia—Imiquimod—skin cancer	0.000307	0.00201	CcSEcCtD
Acetaminophen—PTGS1—mammalian vulva—skin cancer	0.000305	0.00613	CbGeAlD
Acetaminophen—Erythema—Bleomycin—skin cancer	0.000303	0.00199	CcSEcCtD
Acetaminophen—Decreased appetite—Imiquimod—skin cancer	0.000303	0.00199	CcSEcCtD
Acetaminophen—Flushing—Dactinomycin—skin cancer	0.000302	0.00198	CcSEcCtD
Acetaminophen—Hypersensitivity—Vemurafenib—skin cancer	0.000301	0.00198	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Imiquimod—skin cancer	0.000301	0.00198	CcSEcCtD
Acetaminophen—Fatigue—Imiquimod—skin cancer	0.0003	0.00197	CcSEcCtD
Acetaminophen—CYP1A1—female reproductive system—skin cancer	0.000298	0.00598	CbGeAlD
Acetaminophen—Haemoglobin—Temozolomide—skin cancer	0.000295	0.00194	CcSEcCtD
Acetaminophen—Haemorrhage—Temozolomide—skin cancer	0.000294	0.00193	CcSEcCtD
Acetaminophen—Hepatitis—Temozolomide—skin cancer	0.000294	0.00193	CcSEcCtD
Acetaminophen—Asthenia—Vemurafenib—skin cancer	0.000293	0.00193	CcSEcCtD
Acetaminophen—Hallucination—Temozolomide—skin cancer	0.000292	0.00192	CcSEcCtD
Acetaminophen—Chills—Dactinomycin—skin cancer	0.000292	0.00191	CcSEcCtD
Acetaminophen—Urinary tract disorder—Temozolomide—skin cancer	0.00029	0.00191	CcSEcCtD
Acetaminophen—Oedema peripheral—Temozolomide—skin cancer	0.000289	0.0019	CcSEcCtD
Acetaminophen—Pruritus—Vemurafenib—skin cancer	0.000289	0.0019	CcSEcCtD
Acetaminophen—Connective tissue disorder—Temozolomide—skin cancer	0.000289	0.0019	CcSEcCtD
Acetaminophen—Urethral disorder—Temozolomide—skin cancer	0.000288	0.00189	CcSEcCtD
Acetaminophen—Feeling abnormal—Imiquimod—skin cancer	0.000287	0.00189	CcSEcCtD
Acetaminophen—CYP2C9—female reproductive system—skin cancer	0.000287	0.00575	CbGeAlD
Acetaminophen—Gastrointestinal pain—Imiquimod—skin cancer	0.000285	0.00187	CcSEcCtD
Acetaminophen—Erythema—Dactinomycin—skin cancer	0.000283	0.00186	CcSEcCtD
Acetaminophen—Pain in extremity—Docetaxel—skin cancer	0.000282	0.00186	CcSEcCtD
Acetaminophen—CYP2E1—lymphoid tissue—skin cancer	0.000282	0.00565	CbGeAlD
Acetaminophen—Agranulocytosis—Fluorouracil—skin cancer	0.000281	0.00185	CcSEcCtD
Acetaminophen—Ill-defined disorder—Bleomycin—skin cancer	0.000281	0.00185	CcSEcCtD
Acetaminophen—Anaemia—Bleomycin—skin cancer	0.00028	0.00184	CcSEcCtD
Acetaminophen—Diarrhoea—Vemurafenib—skin cancer	0.000279	0.00184	CcSEcCtD
Acetaminophen—TRPV1—Trk receptor signaling mediated by the MAPK pathway—BRAF—skin cancer	0.000278	0.026	CbGpPWpGaD
Acetaminophen—Erythema multiforme—Temozolomide—skin cancer	0.000278	0.00182	CcSEcCtD
Acetaminophen—Urticaria—Imiquimod—skin cancer	0.000277	0.00182	CcSEcCtD
Acetaminophen—SULT2A1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.000276	0.0259	CbGpPWpGaD
Acetaminophen—Abdominal pain—Imiquimod—skin cancer	0.000275	0.00181	CcSEcCtD
Acetaminophen—Body temperature increased—Imiquimod—skin cancer	0.000275	0.00181	CcSEcCtD
Acetaminophen—Eye disorder—Temozolomide—skin cancer	0.000275	0.0018	CcSEcCtD
Acetaminophen—Malaise—Bleomycin—skin cancer	0.000273	0.0018	CcSEcCtD
Acetaminophen—Cardiac disorder—Temozolomide—skin cancer	0.000273	0.00179	CcSEcCtD
Acetaminophen—Flushing—Temozolomide—skin cancer	0.000273	0.00179	CcSEcCtD
Acetaminophen—Haemoglobin—Fluorouracil—skin cancer	0.000272	0.00179	CcSEcCtD
Acetaminophen—CYP2E1—female reproductive system—skin cancer	0.000272	0.00545	CbGeAlD
Acetaminophen—Leukopenia—Bleomycin—skin cancer	0.000271	0.00178	CcSEcCtD
Acetaminophen—Haemorrhage—Fluorouracil—skin cancer	0.000271	0.00178	CcSEcCtD
Acetaminophen—Dizziness—Vemurafenib—skin cancer	0.00027	0.00177	CcSEcCtD
Acetaminophen—Angiopathy—Temozolomide—skin cancer	0.000267	0.00175	CcSEcCtD
Acetaminophen—Immune system disorder—Temozolomide—skin cancer	0.000265	0.00174	CcSEcCtD
Acetaminophen—Mediastinal disorder—Temozolomide—skin cancer	0.000265	0.00174	CcSEcCtD
Acetaminophen—Cough—Bleomycin—skin cancer	0.000265	0.00174	CcSEcCtD
Acetaminophen—Chills—Temozolomide—skin cancer	0.000264	0.00173	CcSEcCtD
Acetaminophen—Ill-defined disorder—Dactinomycin—skin cancer	0.000262	0.00172	CcSEcCtD
Acetaminophen—PTGS1—female reproductive system—skin cancer	0.000262	0.00525	CbGeAlD
Acetaminophen—Anaemia—Dactinomycin—skin cancer	0.000261	0.00172	CcSEcCtD
Acetaminophen—Vomiting—Vemurafenib—skin cancer	0.00026	0.00171	CcSEcCtD
Acetaminophen—PTGS2—lymphoid tissue—skin cancer	0.000259	0.0052	CbGeAlD
Acetaminophen—Chest pain—Bleomycin—skin cancer	0.000258	0.0017	CcSEcCtD
Acetaminophen—Rash—Vemurafenib—skin cancer	0.000258	0.00169	CcSEcCtD
Acetaminophen—Mental disorder—Temozolomide—skin cancer	0.000257	0.00169	CcSEcCtD
Acetaminophen—Dermatitis—Vemurafenib—skin cancer	0.000257	0.00169	CcSEcCtD
Acetaminophen—Hypersensitivity—Imiquimod—skin cancer	0.000257	0.00169	CcSEcCtD
Acetaminophen—Headache—Vemurafenib—skin cancer	0.000256	0.00168	CcSEcCtD
Acetaminophen—Malnutrition—Temozolomide—skin cancer	0.000256	0.00168	CcSEcCtD
Acetaminophen—Erythema—Temozolomide—skin cancer	0.000256	0.00168	CcSEcCtD
Acetaminophen—Discomfort—Bleomycin—skin cancer	0.000255	0.00168	CcSEcCtD
Acetaminophen—Malaise—Dactinomycin—skin cancer	0.000255	0.00168	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000254	0.00167	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000254	0.00167	CcSEcCtD
Acetaminophen—Leukopenia—Dactinomycin—skin cancer	0.000253	0.00166	CcSEcCtD
Acetaminophen—PTGS2—female reproductive system—skin cancer	0.00025	0.00502	CbGeAlD
Acetaminophen—Asthenia—Imiquimod—skin cancer	0.00025	0.00164	CcSEcCtD
Acetaminophen—Confusional state—Bleomycin—skin cancer	0.00025	0.00164	CcSEcCtD
Acetaminophen—CYP1A1—head—skin cancer	0.000249	0.00499	CbGeAlD
Acetaminophen—CYP2A6—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000249	0.0233	CbGpPWpGaD
Acetaminophen—Anaphylactic shock—Bleomycin—skin cancer	0.000247	0.00163	CcSEcCtD
Acetaminophen—Oedema—Bleomycin—skin cancer	0.000247	0.00163	CcSEcCtD
Acetaminophen—Pruritus—Imiquimod—skin cancer	0.000246	0.00162	CcSEcCtD
Acetaminophen—Nausea—Vemurafenib—skin cancer	0.000243	0.00159	CcSEcCtD
Acetaminophen—Thrombocytopenia—Bleomycin—skin cancer	0.000242	0.00159	CcSEcCtD
Acetaminophen—Vision blurred—Temozolomide—skin cancer	0.000241	0.00158	CcSEcCtD
Acetaminophen—Bronchospasm—Docetaxel—skin cancer	0.00024	0.00158	CcSEcCtD
Acetaminophen—Tremor—Temozolomide—skin cancer	0.00024	0.00157	CcSEcCtD
Acetaminophen—Diarrhoea—Imiquimod—skin cancer	0.000238	0.00157	CcSEcCtD
Acetaminophen—Discomfort—Dactinomycin—skin cancer	0.000238	0.00156	CcSEcCtD
Acetaminophen—Ill-defined disorder—Temozolomide—skin cancer	0.000237	0.00156	CcSEcCtD
Acetaminophen—Anaemia—Temozolomide—skin cancer	0.000236	0.00155	CcSEcCtD
Acetaminophen—Anorexia—Bleomycin—skin cancer	0.000236	0.00155	CcSEcCtD
Acetaminophen—Erythema—Fluorouracil—skin cancer	0.000236	0.00155	CcSEcCtD
Acetaminophen—Agitation—Temozolomide—skin cancer	0.000235	0.00154	CcSEcCtD
Acetaminophen—Angioedema—Temozolomide—skin cancer	0.000234	0.00154	CcSEcCtD
Acetaminophen—Pancytopenia—Docetaxel—skin cancer	0.000232	0.00152	CcSEcCtD
Acetaminophen—Hypotension—Bleomycin—skin cancer	0.000231	0.00152	CcSEcCtD
Acetaminophen—Oedema—Dactinomycin—skin cancer	0.000231	0.00152	CcSEcCtD
Acetaminophen—Malaise—Temozolomide—skin cancer	0.000231	0.00152	CcSEcCtD
Acetaminophen—Dizziness—Imiquimod—skin cancer	0.00023	0.00151	CcSEcCtD
Acetaminophen—Leukopenia—Temozolomide—skin cancer	0.000229	0.0015	CcSEcCtD
Acetaminophen—Neutropenia—Docetaxel—skin cancer	0.000228	0.0015	CcSEcCtD
Acetaminophen—CYP2E1—head—skin cancer	0.000227	0.00455	CbGeAlD
Acetaminophen—Palpitations—Temozolomide—skin cancer	0.000226	0.00148	CcSEcCtD
Acetaminophen—Thrombocytopenia—Dactinomycin—skin cancer	0.000226	0.00148	CcSEcCtD
Acetaminophen—Cough—Temozolomide—skin cancer	0.000223	0.00147	CcSEcCtD
Acetaminophen—Vision blurred—Fluorouracil—skin cancer	0.000222	0.00146	CcSEcCtD
Acetaminophen—Convulsion—Temozolomide—skin cancer	0.000222	0.00146	CcSEcCtD
Acetaminophen—Vomiting—Imiquimod—skin cancer	0.000222	0.00145	CcSEcCtD
Acetaminophen—Hypertension—Temozolomide—skin cancer	0.000221	0.00145	CcSEcCtD
Acetaminophen—Dyspnoea—Bleomycin—skin cancer	0.000221	0.00145	CcSEcCtD
Acetaminophen—Anorexia—Dactinomycin—skin cancer	0.00022	0.00145	CcSEcCtD
Acetaminophen—Rash—Imiquimod—skin cancer	0.00022	0.00144	CcSEcCtD
Acetaminophen—Dermatitis—Imiquimod—skin cancer	0.000219	0.00144	CcSEcCtD
Acetaminophen—PTGS1—head—skin cancer	0.000219	0.00439	CbGeAlD
Acetaminophen—CYP3A4—female reproductive system—skin cancer	0.000218	0.00439	CbGeAlD
Acetaminophen—Headache—Imiquimod—skin cancer	0.000218	0.00143	CcSEcCtD
Acetaminophen—CNR1—GPCRs, Other—SMO—skin cancer	0.000218	0.0204	CbGpPWpGaD
Acetaminophen—Anaemia—Fluorouracil—skin cancer	0.000218	0.00143	CcSEcCtD
Acetaminophen—Anxiety—Temozolomide—skin cancer	0.000217	0.00143	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000216	0.00142	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000216	0.00142	CcSEcCtD
Acetaminophen—Discomfort—Temozolomide—skin cancer	0.000215	0.00141	CcSEcCtD
Acetaminophen—Decreased appetite—Bleomycin—skin cancer	0.000215	0.00141	CcSEcCtD
Acetaminophen—CYP2D6—female reproductive system—skin cancer	0.000215	0.00432	CbGeAlD
Acetaminophen—Dry mouth—Temozolomide—skin cancer	0.000213	0.0014	CcSEcCtD
Acetaminophen—Leukopenia—Fluorouracil—skin cancer	0.000211	0.00139	CcSEcCtD
Acetaminophen—Confusional state—Temozolomide—skin cancer	0.000211	0.00138	CcSEcCtD
Acetaminophen—PTGS2—head—skin cancer	0.000209	0.00419	CbGeAlD
Acetaminophen—Anaphylactic shock—Temozolomide—skin cancer	0.000209	0.00137	CcSEcCtD
Acetaminophen—Oedema—Temozolomide—skin cancer	0.000209	0.00137	CcSEcCtD
Acetaminophen—ABCB1—epithelium—skin cancer	0.000208	0.00418	CbGeAlD
Acetaminophen—Nausea—Imiquimod—skin cancer	0.000207	0.00136	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Docetaxel—skin cancer	0.000206	0.00135	CcSEcCtD
Acetaminophen—Nervous system disorder—Temozolomide—skin cancer	0.000205	0.00134	CcSEcCtD
Acetaminophen—Thrombocytopenia—Temozolomide—skin cancer	0.000204	0.00134	CcSEcCtD
Acetaminophen—Convulsion—Fluorouracil—skin cancer	0.000204	0.00134	CcSEcCtD
Acetaminophen—Feeling abnormal—Bleomycin—skin cancer	0.000204	0.00134	CcSEcCtD
Acetaminophen—Agranulocytosis—Docetaxel—skin cancer	0.000203	0.00133	CcSEcCtD
Acetaminophen—Skin disorder—Temozolomide—skin cancer	0.000203	0.00133	CcSEcCtD
Acetaminophen—Hyperhidrosis—Temozolomide—skin cancer	0.000202	0.00133	CcSEcCtD
Acetaminophen—Chest pain—Fluorouracil—skin cancer	0.000201	0.00132	CcSEcCtD
Acetaminophen—Decreased appetite—Dactinomycin—skin cancer	0.000201	0.00132	CcSEcCtD
Acetaminophen—Fatigue—Dactinomycin—skin cancer	0.000199	0.00131	CcSEcCtD
Acetaminophen—Anorexia—Temozolomide—skin cancer	0.000199	0.00131	CcSEcCtD
Acetaminophen—Discomfort—Fluorouracil—skin cancer	0.000198	0.0013	CcSEcCtD
Acetaminophen—Urticaria—Bleomycin—skin cancer	0.000197	0.00129	CcSEcCtD
Acetaminophen—Haemoglobin—Docetaxel—skin cancer	0.000196	0.00129	CcSEcCtD
Acetaminophen—Body temperature increased—Bleomycin—skin cancer	0.000196	0.00129	CcSEcCtD
Acetaminophen—Hepatitis—Docetaxel—skin cancer	0.000195	0.00128	CcSEcCtD
Acetaminophen—Haemorrhage—Docetaxel—skin cancer	0.000195	0.00128	CcSEcCtD
Acetaminophen—Confusional state—Fluorouracil—skin cancer	0.000194	0.00127	CcSEcCtD
Acetaminophen—Urinary tract disorder—Docetaxel—skin cancer	0.000193	0.00127	CcSEcCtD
Acetaminophen—Oedema peripheral—Docetaxel—skin cancer	0.000193	0.00126	CcSEcCtD
Acetaminophen—Oedema—Fluorouracil—skin cancer	0.000192	0.00126	CcSEcCtD
Acetaminophen—Anaphylactic shock—Fluorouracil—skin cancer	0.000192	0.00126	CcSEcCtD
Acetaminophen—Connective tissue disorder—Docetaxel—skin cancer	0.000192	0.00126	CcSEcCtD
Acetaminophen—Urethral disorder—Docetaxel—skin cancer	0.000192	0.00126	CcSEcCtD
Acetaminophen—Feeling abnormal—Dactinomycin—skin cancer	0.00019	0.00125	CcSEcCtD
Acetaminophen—Insomnia—Temozolomide—skin cancer	0.000189	0.00124	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Dactinomycin—skin cancer	0.000189	0.00124	CcSEcCtD
Acetaminophen—Nervous system disorder—Fluorouracil—skin cancer	0.000189	0.00124	CcSEcCtD
Acetaminophen—Thrombocytopenia—Fluorouracil—skin cancer	0.000188	0.00124	CcSEcCtD
Acetaminophen—Tachycardia—Fluorouracil—skin cancer	0.000188	0.00123	CcSEcCtD
Acetaminophen—Dyspnoea—Temozolomide—skin cancer	0.000186	0.00122	CcSEcCtD
Acetaminophen—Somnolence—Temozolomide—skin cancer	0.000186	0.00122	CcSEcCtD
Acetaminophen—Erythema multiforme—Docetaxel—skin cancer	0.000185	0.00121	CcSEcCtD
Acetaminophen—Dyspepsia—Temozolomide—skin cancer	0.000184	0.00121	CcSEcCtD
Acetaminophen—Anorexia—Fluorouracil—skin cancer	0.000183	0.0012	CcSEcCtD
Acetaminophen—Eye disorder—Docetaxel—skin cancer	0.000183	0.0012	CcSEcCtD
Acetaminophen—Body temperature increased—Dactinomycin—skin cancer	0.000182	0.0012	CcSEcCtD
Acetaminophen—Abdominal pain—Dactinomycin—skin cancer	0.000182	0.0012	CcSEcCtD
Acetaminophen—Hypersensitivity—Bleomycin—skin cancer	0.000182	0.0012	CcSEcCtD
Acetaminophen—Decreased appetite—Temozolomide—skin cancer	0.000181	0.00119	CcSEcCtD
Acetaminophen—Flushing—Docetaxel—skin cancer	0.000181	0.00119	CcSEcCtD
Acetaminophen—Cardiac disorder—Docetaxel—skin cancer	0.000181	0.00119	CcSEcCtD
Acetaminophen—ABCB1—mammalian vulva—skin cancer	0.000181	0.00363	CbGeAlD
Acetaminophen—Gastrointestinal disorder—Temozolomide—skin cancer	0.00018	0.00118	CcSEcCtD
Acetaminophen—Fatigue—Temozolomide—skin cancer	0.00018	0.00118	CcSEcCtD
Acetaminophen—Hypotension—Fluorouracil—skin cancer	0.00018	0.00118	CcSEcCtD
Acetaminophen—CYP2D6—head—skin cancer	0.00018	0.00361	CbGeAlD
Acetaminophen—Constipation—Temozolomide—skin cancer	0.000179	0.00117	CcSEcCtD
Acetaminophen—Asthenia—Bleomycin—skin cancer	0.000178	0.00117	CcSEcCtD
Acetaminophen—Angiopathy—Docetaxel—skin cancer	0.000177	0.00116	CcSEcCtD
Acetaminophen—Immune system disorder—Docetaxel—skin cancer	0.000177	0.00116	CcSEcCtD
Acetaminophen—Mediastinal disorder—Docetaxel—skin cancer	0.000176	0.00116	CcSEcCtD
Acetaminophen—Chills—Docetaxel—skin cancer	0.000175	0.00115	CcSEcCtD
Acetaminophen—Pruritus—Bleomycin—skin cancer	0.000175	0.00115	CcSEcCtD
Acetaminophen—TRPV1—Trk receptor signaling mediated by the MAPK pathway—NRAS—skin cancer	0.000175	0.0163	CbGpPWpGaD
Acetaminophen—CYP1A1—lymph node—skin cancer	0.000174	0.0035	CbGeAlD
Acetaminophen—Insomnia—Fluorouracil—skin cancer	0.000174	0.00114	CcSEcCtD
Acetaminophen—Feeling abnormal—Temozolomide—skin cancer	0.000172	0.00113	CcSEcCtD
Acetaminophen—Dyspnoea—Fluorouracil—skin cancer	0.000171	0.00113	CcSEcCtD
Acetaminophen—Mental disorder—Docetaxel—skin cancer	0.000171	0.00112	CcSEcCtD
Acetaminophen—Somnolence—Fluorouracil—skin cancer	0.000171	0.00112	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Temozolomide—skin cancer	0.000171	0.00112	CcSEcCtD
Acetaminophen—Erythema—Docetaxel—skin cancer	0.00017	0.00112	CcSEcCtD
Acetaminophen—Malnutrition—Docetaxel—skin cancer	0.00017	0.00112	CcSEcCtD
Acetaminophen—Hypersensitivity—Dactinomycin—skin cancer	0.00017	0.00112	CcSEcCtD
Acetaminophen—Dyspepsia—Fluorouracil—skin cancer	0.000169	0.00111	CcSEcCtD
Acetaminophen—Decreased appetite—Fluorouracil—skin cancer	0.000167	0.0011	CcSEcCtD
Acetaminophen—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—skin cancer	0.000167	0.0156	CbGpPWpGaD
Acetaminophen—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000166	0.00109	CcSEcCtD
Acetaminophen—Urticaria—Temozolomide—skin cancer	0.000166	0.00109	CcSEcCtD
Acetaminophen—Asthenia—Dactinomycin—skin cancer	0.000166	0.00109	CcSEcCtD
Acetaminophen—Body temperature increased—Temozolomide—skin cancer	0.000165	0.00108	CcSEcCtD
Acetaminophen—Abdominal pain—Temozolomide—skin cancer	0.000165	0.00108	CcSEcCtD
Acetaminophen—Muscle spasms—Docetaxel—skin cancer	0.000164	0.00107	CcSEcCtD
Acetaminophen—ABCB1—lymphoid tissue—skin cancer	0.00016	0.00322	CbGeAlD
Acetaminophen—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.000159	0.0148	CbGpPWpGaD
Acetaminophen—Feeling abnormal—Fluorouracil—skin cancer	0.000159	0.00104	CcSEcCtD
Acetaminophen—Diarrhoea—Dactinomycin—skin cancer	0.000158	0.00104	CcSEcCtD
Acetaminophen—Vomiting—Bleomycin—skin cancer	0.000157	0.00103	CcSEcCtD
Acetaminophen—Anaemia—Docetaxel—skin cancer	0.000157	0.00103	CcSEcCtD
Acetaminophen—Rash—Bleomycin—skin cancer	0.000156	0.00102	CcSEcCtD
Acetaminophen—Dermatitis—Bleomycin—skin cancer	0.000156	0.00102	CcSEcCtD
Acetaminophen—ABCB1—female reproductive system—skin cancer	0.000155	0.00311	CbGeAlD
Acetaminophen—Hypersensitivity—Temozolomide—skin cancer	0.000154	0.00101	CcSEcCtD
Acetaminophen—PTGS1—lymph node—skin cancer	0.000153	0.00307	CbGeAlD
Acetaminophen—Urticaria—Fluorouracil—skin cancer	0.000153	0.001	CcSEcCtD
Acetaminophen—Leukopenia—Docetaxel—skin cancer	0.000152	0.001	CcSEcCtD
Acetaminophen—Body temperature increased—Fluorouracil—skin cancer	0.000152	0.000999	CcSEcCtD
Acetaminophen—TRPV1—Trk receptor signaling mediated by the MAPK pathway—KRAS—skin cancer	0.00015	0.0141	CbGpPWpGaD
Acetaminophen—Palpitations—Docetaxel—skin cancer	0.00015	0.000987	CcSEcCtD
Acetaminophen—Asthenia—Temozolomide—skin cancer	0.00015	0.000984	CcSEcCtD
Acetaminophen—Cough—Docetaxel—skin cancer	0.000148	0.000975	CcSEcCtD
Acetaminophen—Pruritus—Temozolomide—skin cancer	0.000148	0.00097	CcSEcCtD
Acetaminophen—Convulsion—Docetaxel—skin cancer	0.000147	0.000968	CcSEcCtD
Acetaminophen—Nausea—Bleomycin—skin cancer	0.000147	0.000966	CcSEcCtD
Acetaminophen—Hypertension—Docetaxel—skin cancer	0.000147	0.000965	CcSEcCtD
Acetaminophen—Vomiting—Dactinomycin—skin cancer	0.000147	0.000964	CcSEcCtD
Acetaminophen—PTGS2—lymph node—skin cancer	0.000146	0.00294	CbGeAlD
Acetaminophen—Rash—Dactinomycin—skin cancer	0.000146	0.000956	CcSEcCtD
Acetaminophen—Chest pain—Docetaxel—skin cancer	0.000145	0.000951	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000144	0.000945	CcSEcCtD
Acetaminophen—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—skin cancer	0.000144	0.0134	CbGpPWpGaD
Acetaminophen—Diarrhoea—Temozolomide—skin cancer	0.000143	0.000938	CcSEcCtD
Acetaminophen—Hypersensitivity—Fluorouracil—skin cancer	0.000142	0.000931	CcSEcCtD
Acetaminophen—Dry mouth—Docetaxel—skin cancer	0.000142	0.00093	CcSEcCtD
Acetaminophen—CNR1—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00014	0.0131	CbGpPWpGaD
Acetaminophen—Confusional state—Docetaxel—skin cancer	0.00014	0.000919	CcSEcCtD
Acetaminophen—Anaphylactic shock—Docetaxel—skin cancer	0.000139	0.000912	CcSEcCtD
Acetaminophen—Oedema—Docetaxel—skin cancer	0.000139	0.000912	CcSEcCtD
Acetaminophen—Dizziness—Temozolomide—skin cancer	0.000138	0.000907	CcSEcCtD
Acetaminophen—Nausea—Dactinomycin—skin cancer	0.000137	0.000901	CcSEcCtD
Acetaminophen—Shock—Docetaxel—skin cancer	0.000137	0.000897	CcSEcCtD
Acetaminophen—Nervous system disorder—Docetaxel—skin cancer	0.000136	0.000894	CcSEcCtD
Acetaminophen—Pruritus—Fluorouracil—skin cancer	0.000136	0.000894	CcSEcCtD
Acetaminophen—UGT1A9—PPARA activates gene expression—PLIN2—skin cancer	0.000136	0.0127	CbGpPWpGaD
Acetaminophen—Thrombocytopenia—Docetaxel—skin cancer	0.000136	0.000893	CcSEcCtD
Acetaminophen—Tachycardia—Docetaxel—skin cancer	0.000135	0.00089	CcSEcCtD
Acetaminophen—Skin disorder—Docetaxel—skin cancer	0.000135	0.000886	CcSEcCtD
Acetaminophen—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—skin cancer	0.000134	0.0126	CbGpPWpGaD
Acetaminophen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.000133	0.0125	CbGpPWpGaD
Acetaminophen—Vomiting—Temozolomide—skin cancer	0.000133	0.000872	CcSEcCtD
Acetaminophen—Anorexia—Docetaxel—skin cancer	0.000132	0.000869	CcSEcCtD
Acetaminophen—Rash—Temozolomide—skin cancer	0.000132	0.000865	CcSEcCtD
Acetaminophen—Diarrhoea—Fluorouracil—skin cancer	0.000132	0.000864	CcSEcCtD
Acetaminophen—Dermatitis—Temozolomide—skin cancer	0.000132	0.000864	CcSEcCtD
Acetaminophen—Headache—Temozolomide—skin cancer	0.000131	0.000859	CcSEcCtD
Acetaminophen—Hypotension—Docetaxel—skin cancer	0.00013	0.000852	CcSEcCtD
Acetaminophen—ABCB1—head—skin cancer	0.000129	0.00259	CbGeAlD
Acetaminophen—TRPV1—Trk receptor signaling mediated by the MAPK pathway—HRAS—skin cancer	0.000128	0.012	CbGpPWpGaD
Acetaminophen—Dizziness—Fluorouracil—skin cancer	0.000127	0.000835	CcSEcCtD
Acetaminophen—CNR1—GPCR ligand binding—PTCH2—skin cancer	0.000127	0.0118	CbGpPWpGaD
Acetaminophen—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.000126	0.0118	CbGpPWpGaD
Acetaminophen—Insomnia—Docetaxel—skin cancer	0.000126	0.000825	CcSEcCtD
Acetaminophen—Nausea—Temozolomide—skin cancer	0.000124	0.000814	CcSEcCtD
Acetaminophen—Dyspnoea—Docetaxel—skin cancer	0.000124	0.000813	CcSEcCtD
Acetaminophen—Somnolence—Docetaxel—skin cancer	0.000123	0.000811	CcSEcCtD
Acetaminophen—Vomiting—Fluorouracil—skin cancer	0.000122	0.000803	CcSEcCtD
Acetaminophen—Dyspepsia—Docetaxel—skin cancer	0.000122	0.000803	CcSEcCtD
Acetaminophen—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—skin cancer	0.000122	0.0114	CbGpPWpGaD
Acetaminophen—Rash—Fluorouracil—skin cancer	0.000121	0.000797	CcSEcCtD
Acetaminophen—Dermatitis—Fluorouracil—skin cancer	0.000121	0.000796	CcSEcCtD
Acetaminophen—Decreased appetite—Docetaxel—skin cancer	0.000121	0.000793	CcSEcCtD
Acetaminophen—Headache—Fluorouracil—skin cancer	0.000121	0.000791	CcSEcCtD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00012	0.0112	CbGpPWpGaD
Acetaminophen—Gastrointestinal disorder—Docetaxel—skin cancer	0.00012	0.000787	CcSEcCtD
Acetaminophen—Fatigue—Docetaxel—skin cancer	0.00012	0.000786	CcSEcCtD
Acetaminophen—Constipation—Docetaxel—skin cancer	0.000119	0.00078	CcSEcCtD
Acetaminophen—SULT2A1—E2F transcription factor network—CDKN2A—skin cancer	0.000116	0.0109	CbGpPWpGaD
Acetaminophen—UGT1A9—PPAR Alpha Pathway—CDK4—skin cancer	0.000115	0.0108	CbGpPWpGaD
Acetaminophen—Feeling abnormal—Docetaxel—skin cancer	0.000114	0.000751	CcSEcCtD
Acetaminophen—Nausea—Fluorouracil—skin cancer	0.000114	0.00075	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Docetaxel—skin cancer	0.000114	0.000746	CcSEcCtD
Acetaminophen—SULT2A1—Corticotropin-releasing hormone—BRAF—skin cancer	0.000112	0.0105	CbGpPWpGaD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000111	0.0104	CbGpPWpGaD
Acetaminophen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—skin cancer	0.00011	0.0103	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.00011	0.0103	CbGpPWpGaD
Acetaminophen—Body temperature increased—Docetaxel—skin cancer	0.00011	0.000721	CcSEcCtD
Acetaminophen—Abdominal pain—Docetaxel—skin cancer	0.00011	0.000721	CcSEcCtD
Acetaminophen—Hypersensitivity—Docetaxel—skin cancer	0.000102	0.000672	CcSEcCtD
Acetaminophen—Asthenia—Docetaxel—skin cancer	9.96e-05	0.000654	CcSEcCtD
Acetaminophen—Pruritus—Docetaxel—skin cancer	9.82e-05	0.000645	CcSEcCtD
Acetaminophen—Diarrhoea—Docetaxel—skin cancer	9.5e-05	0.000624	CcSEcCtD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	9.39e-05	0.00879	CbGpPWpGaD
Acetaminophen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—skin cancer	9.36e-05	0.00876	CbGpPWpGaD
Acetaminophen—CNR1—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	9.23e-05	0.00863	CbGpPWpGaD
Acetaminophen—Dizziness—Docetaxel—skin cancer	9.18e-05	0.000603	CcSEcCtD
Acetaminophen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	9.18e-05	0.00859	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—MC1R—skin cancer	9.15e-05	0.00857	CbGpPWpGaD
Acetaminophen—ABCB1—lymph node—skin cancer	9.05e-05	0.00182	CbGeAlD
Acetaminophen—Vomiting—Docetaxel—skin cancer	8.83e-05	0.00058	CcSEcCtD
Acetaminophen—Rash—Docetaxel—skin cancer	8.75e-05	0.000575	CcSEcCtD
Acetaminophen—CYP2A6—Fluoropyrimidine Activity—ERCC2—skin cancer	8.75e-05	0.00818	CbGpPWpGaD
Acetaminophen—Dermatitis—Docetaxel—skin cancer	8.75e-05	0.000574	CcSEcCtD
Acetaminophen—Headache—Docetaxel—skin cancer	8.7e-05	0.000571	CcSEcCtD
Acetaminophen—PTGS1—Overview of nanoparticle effects—PTGS2—skin cancer	8.63e-05	0.00807	CbGpPWpGaD
Acetaminophen—Nausea—Docetaxel—skin cancer	8.25e-05	0.000542	CcSEcCtD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	7.91e-05	0.0074	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—RHOU—skin cancer	7.86e-05	0.00735	CbGpPWpGaD
Acetaminophen—CYP1A1—PPARA activates gene expression—PLIN2—skin cancer	7.82e-05	0.00731	CbGpPWpGaD
Acetaminophen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	7.65e-05	0.00716	CbGpPWpGaD
Acetaminophen—PTGS1—Eicosanoid Synthesis—PTGS2—skin cancer	7.16e-05	0.0067	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—CSPG4—skin cancer	6.71e-05	0.00628	CbGpPWpGaD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—skin cancer	6.53e-05	0.00611	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—SHH—skin cancer	6.52e-05	0.0061	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—PTCH2—skin cancer	6.5e-05	0.00608	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PLIN2—skin cancer	6.47e-05	0.00605	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—PTCH1—skin cancer	6.18e-05	0.00579	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—SMO—skin cancer	6.18e-05	0.00579	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—PTGER4—skin cancer	6.02e-05	0.00563	CbGpPWpGaD
Acetaminophen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—skin cancer	5.99e-05	0.0056	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PLIN2—skin cancer	5.7e-05	0.00533	CbGpPWpGaD
Acetaminophen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	5.27e-05	0.00493	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—CSPG4—skin cancer	5.21e-05	0.00488	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—MC1R—skin cancer	5.17e-05	0.00484	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PLIN2—skin cancer	4.9e-05	0.00459	CbGpPWpGaD
Acetaminophen—PTGS1—Overview of nanoparticle effects—IL6—skin cancer	4.7e-05	0.0044	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—MC1R—skin cancer	4.7e-05	0.0044	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PLIN2—skin cancer	4.68e-05	0.00438	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—CSPG4—skin cancer	4.59e-05	0.0043	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—skin cancer	4.42e-05	0.00413	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PLIN2—skin cancer	4.4e-05	0.00411	CbGpPWpGaD
Acetaminophen—PTGS1—Arachidonic acid metabolism—PTGS2—skin cancer	3.98e-05	0.00372	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—CSPG4—skin cancer	3.95e-05	0.0037	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PTCH2—skin cancer	3.84e-05	0.00359	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—CSPG4—skin cancer	3.77e-05	0.00353	CbGpPWpGaD
Acetaminophen—PTGS2—Overview of nanoparticle effects—IL6—skin cancer	3.73e-05	0.00349	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PLIN2—skin cancer	3.67e-05	0.00343	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.65e-05	0.00342	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—ENO2—skin cancer	3.54e-05	0.00332	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—CSPG4—skin cancer	3.54e-05	0.00332	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—PTGER4—skin cancer	3.4e-05	0.00318	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—SHH—skin cancer	3.35e-05	0.00313	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.32e-05	0.0031	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—PTCH1—skin cancer	3.17e-05	0.00297	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—SMO—skin cancer	3.17e-05	0.00297	CbGpPWpGaD
Acetaminophen—CNR1—BDNF signaling pathway—HRAS—skin cancer	3.16e-05	0.00296	CbGpPWpGaD
Acetaminophen—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	3.12e-05	0.00292	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—ENO2—skin cancer	3.12e-05	0.00292	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	3.1e-05	0.0029	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—PTGER4—skin cancer	3.09e-05	0.00289	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	3e-05	0.0028	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.98e-05	0.00279	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—CSPG4—skin cancer	2.96e-05	0.00277	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.94e-05	0.00275	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—GLI2—skin cancer	2.91e-05	0.00272	CbGpPWpGaD
Acetaminophen—CYP1A1—Arachidonic acid metabolism—PTGS2—skin cancer	2.8e-05	0.00262	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	2.8e-05	0.00262	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MC1R—skin cancer	2.78e-05	0.0026	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—GLI1—skin cancer	2.74e-05	0.00256	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—ENO2—skin cancer	2.69e-05	0.00251	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.63e-05	0.00246	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SUFU—skin cancer	2.59e-05	0.00243	CbGpPWpGaD
Acetaminophen—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	2.57e-05	0.0024	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—ENO2—skin cancer	2.56e-05	0.0024	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—PTGS2—skin cancer	2.53e-05	0.00237	CbGpPWpGaD
Acetaminophen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	2.5e-05	0.00234	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—ENO2—skin cancer	2.41e-05	0.00225	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.36e-05	0.00221	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.33e-05	0.00218	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.26e-05	0.00212	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—CDKN2A—skin cancer	2.23e-05	0.00209	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—CDK4—skin cancer	2.22e-05	0.00208	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	2.2e-05	0.00206	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.1e-05	0.00197	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.1e-05	0.00196	CbGpPWpGaD
Acetaminophen—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	2.09e-05	0.00196	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.09e-05	0.00195	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—ERCC2—skin cancer	2.06e-05	0.00193	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—ENO2—skin cancer	2.01e-05	0.00188	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.01e-05	0.00188	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SHH—skin cancer	1.98e-05	0.00185	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—RASA1—skin cancer	1.97e-05	0.00184	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.92e-05	0.0018	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.92e-05	0.0018	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	1.91e-05	0.00179	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PTCH1—skin cancer	1.87e-05	0.00175	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SMO—skin cancer	1.87e-05	0.00175	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PTGER4—skin cancer	1.82e-05	0.00171	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—ERCC2—skin cancer	1.81e-05	0.0017	CbGpPWpGaD
Acetaminophen—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	1.79e-05	0.00167	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.71e-05	0.0016	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PLIN2—skin cancer	1.63e-05	0.00152	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PLIN2—skin cancer	1.63e-05	0.00152	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—NRAS—skin cancer	1.62e-05	0.00152	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—FOXO4—skin cancer	1.61e-05	0.00151	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.57e-05	0.00147	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—ERCC2—skin cancer	1.56e-05	0.00146	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.51e-05	0.00141	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.51e-05	0.00141	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—ERCC2—skin cancer	1.49e-05	0.00139	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	1.49e-05	0.00139	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—ERCC2—skin cancer	1.4e-05	0.00131	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	1.4e-05	0.00131	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	1.38e-05	0.00129	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.34e-05	0.00125	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PLIN2—skin cancer	1.33e-05	0.00124	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CSPG4—skin cancer	1.31e-05	0.00123	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CSPG4—skin cancer	1.31e-05	0.00123	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	1.28e-05	0.0012	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PLIN2—skin cancer	1.25e-05	0.00117	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PTGS2—skin cancer	1.23e-05	0.00116	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	1.19e-05	0.00111	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—ERCC2—skin cancer	1.17e-05	0.00109	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	1.09e-05	0.00102	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.09e-05	0.00102	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PTGS2—skin cancer	1.09e-05	0.00102	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TERT—skin cancer	1.08e-05	0.00101	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.07e-05	0.001	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CSPG4—skin cancer	1.07e-05	0.001	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PLIN2—skin cancer	1.05e-05	0.000985	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CSPG4—skin cancer	1.01e-05	0.000948	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CSPG4—skin cancer	1.01e-05	0.000946	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PLIN2—skin cancer	9.91e-06	0.000928	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TP53—skin cancer	9.46e-06	0.000885	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PTGS2—skin cancer	9.36e-06	0.000875	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PLIN2—skin cancer	9.35e-06	0.000875	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—NRAS—skin cancer	9.07e-06	0.000849	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PTGS2—skin cancer	8.93e-06	0.000835	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—ENO2—skin cancer	8.92e-06	0.000834	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—ENO2—skin cancer	8.92e-06	0.000834	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—IL6—skin cancer	8.66e-06	0.00081	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PLIN2—skin cancer	8.57e-06	0.000802	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—BRAF—skin cancer	8.53e-06	0.000798	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CSPG4—skin cancer	8.49e-06	0.000794	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PTGS2—skin cancer	8.39e-06	0.000785	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CSPG4—skin cancer	7.99e-06	0.000748	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—KRAS—skin cancer	7.81e-06	0.000731	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	7.66e-06	0.000717	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CSPG4—skin cancer	7.53e-06	0.000705	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PLIN2—skin cancer	7.47e-06	0.000699	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ENO2—skin cancer	7.27e-06	0.00068	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	7.24e-06	0.000677	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PLIN2—skin cancer	7.04e-06	0.000658	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PTGS2—skin cancer	7e-06	0.000655	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PLIN2—skin cancer	6.97e-06	0.000653	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.97e-06	0.000653	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CSPG4—skin cancer	6.91e-06	0.000646	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—SHH—skin cancer	6.89e-06	0.000645	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ENO2—skin cancer	6.89e-06	0.000645	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ENO2—skin cancer	6.87e-06	0.000643	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—HRAS—skin cancer	6.64e-06	0.000621	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	6.43e-06	0.000602	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—IL6—skin cancer	6.35e-06	0.000594	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CSPG4—skin cancer	6.02e-06	0.000563	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PLIN2—skin cancer	5.96e-06	0.000558	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ENO2—skin cancer	5.77e-06	0.00054	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.68e-06	0.000532	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CSPG4—skin cancer	5.67e-06	0.000531	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CSPG4—skin cancer	5.62e-06	0.000526	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—FOXO4—skin cancer	5.62e-06	0.000526	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ENO2—skin cancer	5.43e-06	0.000508	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—NRAS—skin cancer	5.36e-06	0.000501	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—ERCC2—skin cancer	5.18e-06	0.000485	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—ERCC2—skin cancer	5.18e-06	0.000485	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	5.13e-06	0.00048	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ENO2—skin cancer	5.12e-06	0.000479	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CSPG4—skin cancer	4.8e-06	0.00045	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ENO2—skin cancer	4.7e-06	0.000439	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KRAS—skin cancer	4.61e-06	0.000432	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PLIN2—skin cancer	4.6e-06	0.00043	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.56e-06	0.000427	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ERCC2—skin cancer	4.22e-06	0.000395	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—skin cancer	4.1e-06	0.000384	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ENO2—skin cancer	4.09e-06	0.000383	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.01e-06	0.000375	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ERCC2—skin cancer	4e-06	0.000374	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ERCC2—skin cancer	3.99e-06	0.000374	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—HRAS—skin cancer	3.92e-06	0.000367	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ENO2—skin cancer	3.85e-06	0.000361	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ENO2—skin cancer	3.82e-06	0.000358	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IL6—skin cancer	3.75e-06	0.000351	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TERT—skin cancer	3.75e-06	0.000351	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CSPG4—skin cancer	3.71e-06	0.000347	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.67e-06	0.000344	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ERCC2—skin cancer	3.35e-06	0.000314	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ENO2—skin cancer	3.27e-06	0.000306	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ERCC2—skin cancer	3.16e-06	0.000295	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTGS2—skin cancer	3.11e-06	0.000291	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTGS2—skin cancer	3.11e-06	0.000291	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.99e-06	0.00028	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ERCC2—skin cancer	2.97e-06	0.000278	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—BRAF—skin cancer	2.97e-06	0.000278	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ERCC2—skin cancer	2.73e-06	0.000255	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.55e-06	0.000239	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTGS2—skin cancer	2.53e-06	0.000237	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ENO2—skin cancer	2.52e-06	0.000236	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTGS2—skin cancer	2.39e-06	0.000224	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ERCC2—skin cancer	2.38e-06	0.000222	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ERCC2—skin cancer	2.24e-06	0.00021	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ERCC2—skin cancer	2.22e-06	0.000208	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ERCC2—skin cancer	1.9e-06	0.000177	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTGS2—skin cancer	1.89e-06	0.000177	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NRAS—skin cancer	1.87e-06	0.000175	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTGS2—skin cancer	1.78e-06	0.000167	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS2—skin cancer	1.64e-06	0.000153	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KRAS—skin cancer	1.61e-06	0.00015	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ERCC2—skin cancer	1.46e-06	0.000137	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS2—skin cancer	1.42e-06	0.000133	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HRAS—skin cancer	1.37e-06	0.000128	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS2—skin cancer	1.34e-06	0.000126	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS2—skin cancer	1.33e-06	0.000125	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—IL6—skin cancer	1.31e-06	0.000122	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS2—skin cancer	1.14e-06	0.000106	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS2—skin cancer	8.78e-07	8.21e-05	CbGpPWpGaD
